What is the recommended treatment for amoebiasis (Entamoeba histolytica)?

Treatment for Amoebiasis (Entamoeba histolytica)

For invasive amoebiasis including amoebic liver abscess and amoebic colitis, initiate metronidazole 500 mg orally three times daily for 7-10 days (or tinidazole 2 g daily for 3 days as an alternative with less nausea), followed by a luminal amebicide such as diloxanide furoate 500 mg orally three times daily or paromomycin 30 mg/kg per day in 3 divided doses for 10 days to prevent relapse. 1

Treatment Algorithm Based on Clinical Presentation

Invasive Intestinal Disease (Amoebic Colitis/Dysentery)

First-line tissue amebicide:

• Metronidazole 500 mg orally three times daily for 7-10 days achieves cure rates exceeding 90% 1, 2, 3, 4
• Alternative: Tinidazole 2 g orally daily for 3 days - produces less nausea and comparable efficacy 1

Followed by luminal amebicide (mandatory for all patients):

• Diloxanide furoate 500 mg orally three times daily for 10 days 1, 5
• Alternative: Paromomycin 30 mg/kg per day orally in 3 divided doses for 10 days 1, 6

The luminal agent is essential even in patients with negative stool microscopy to eradicate intestinal colonization and prevent relapse 1, 5

Amoebic Liver Abscess

Initial therapy:

• Metronidazole 500 mg orally three times daily for 7-10 days 1, 3
• Tinidazole 2 g orally daily for 3 days as alternative 1

Most patients respond within 72-96 hours 1. Clinical presentation typically includes abdominal pain (72-95% of cases), fever (67-98%), and hepatomegaly (43-93%), with only 20% having prior dysentery history 1

Followed by luminal amebicide:

• Diloxanide furoate 500 mg orally three times daily for 10 days OR paromomycin 30 mg/kg per day in 3 divided doses for 10 days 1

Drainage indications (rarely required):

• Diagnostic uncertainty between amoebic and pyogenic abscess 1
• Symptoms persisting after 4 days of treatment 1
• Radiological evidence of imminent rupture, particularly left-lobe abscesses threatening pericardium 1

Asymptomatic Intestinal Colonization

Luminal amebicide alone:

• Diloxanide furoate 500 mg orally three times daily for 10 days - achieves 81-96% parasite clearance 5, 6
• Alternative: Paromomycin 1500 mg daily for 9-10 days 6

Diloxanide acts by blocking protein synthesis in trophozoites, preventing conversion to virulent cyst forms 5

Special Populations

HIV-Infected Patients and Men Who Have Sex With Men (MSM)

• Same treatment regimen as immunocompetent patients: tissue amebicide followed by luminal agent 4
• MSM engaging in oral-anal sex have increased prevalence of invasive amoebiasis 4
• Treatment with luminal agents is critical to prevent transmission to sexual partners 4

Patients with Systemic Inflammatory Response

When diagnostic uncertainty exists between amoebic and pyogenic liver abscess:

• Initiate broad-spectrum antibiotics (e.g., ceftriaxone plus metronidazole) until diagnosis confirmed 1
• Amoebic serology (indirect haemagglutination) has >90% sensitivity and results available within 24 hours 1

Common Pitfalls and Caveats

Critical errors to avoid:

• Never omit the luminal amebicide - tissue agents like metronidazole alone do not eradicate intestinal colonization, leading to relapse and continued transmission 1, 4
• Do not rely on stool microscopy alone - faecal microscopy is usually negative in amoebic liver abscess patients 1
• Avoid routine drainage - surgical or percutaneous drainage is rarely needed and should be reserved for specific indications 1

Adverse effects:

• Diloxanide: flatulence, anorexia, headache, urticaria 5
• Paromomycin: diarrhea (13.8%), gastrointestinal symptoms that resolve after treatment completion 6
• HIV infection does not increase adverse effect incidence 6

Diagnostic Considerations

High-yield diagnostic approach:

• Amoebic serology (indirect haemagglutination) for suspected liver abscess - >90% sensitivity 1
• Ultrasound for all suspected liver abscess cases; CT if ultrasound negative with high clinical suspicion 1
• Specific antigen detection or PCR-based assays for intestinal disease - microscopy lacks sensitivity and specificity 1, 4
• Neutrophil leucocytosis >10×10⁹/L, raised inflammatory markers, elevated alkaline phosphatase common in liver abscess 1

Human amoebiasis remains a significant cause of parasitic mortality globally, with E. histolytica being the fourth leading parasitic cause of death 2, 7, 8. The two-stage treatment approach targeting both tissue invasion and luminal colonization is essential for cure and prevention of transmission 1, 4.